CTLA4 and neoplasm: As expected, after treatment with anti‐PD‐1 or anti‐CTLA‐4, the degree of tumor reduction in the Ncr1iCre/+Casp8fl/fl mice was more significant than that in the Casp8fl/fl mice (Figure 7C‐E).